protein folding of a biopharmaceutical — hcd83
DESCRIPTION
Protein Folding of A Biopharmaceutical — hCD83. Lin Zhang Chemical Engineering Department. Biopharmaceuticals. Proteins In use: Insulin tPA Potential use: Human CD83. Outlines. Backgrounds of hCD83 Preliminary Results and Discussion. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/1.jpg)
Protein Folding of A Biopharmaceutical — hCD83
Lin Zhang
Chemical Engineering
Department
![Page 2: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/2.jpg)
Biopharmaceuticals
Proteins
In use: Insulin tPA
Potential use: Human CD83
![Page 3: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/3.jpg)
Outlines
Backgrounds of hCD83
Preliminary Results and Discussion
![Page 4: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/4.jpg)
Human CD83 (hCD83)
Human CD83 is expressed predominantly on the surface of dendritic cells (DCs)
DCs are the most potent antigen presenting cells of the immune system
Glycoprotein CD83 is one of the best-known maturation markers for human DCs
![Page 5: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/5.jpg)
Backgrounds
hCD83
ArgosDC Bio
Production
Preclinical Trial
![Page 6: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/6.jpg)
Backgrounds
Insulin
![Page 7: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/7.jpg)
Backgrounds
What we are interested in:
Dynamic process of protein folding Protein Aggregation 3D Structure
![Page 8: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/8.jpg)
Backgrounds
FDA Approval
3D Structure
Crystallography
![Page 9: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/9.jpg)
3D Structure Prediction Flowchart
Target Sequence
Homologous in PDB
Secondary Structure
Comparative Modeling
Tertiary Structure
Conserved Domain
Yes No
ⅡⅠ
Comparison
![Page 10: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/10.jpg)
Preliminary Results
Database Searching Protein-Protein Blast
Descriptions
![Page 11: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/11.jpg)
Preliminary Results
![Page 12: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/12.jpg)
Preliminary Results
1MCP_H
Class: All beta proteins
Fold: Immunoglobulin-like beta-sandwich
sandwich; 7 strands in 2 sheets; greek-key some members of the fold have additional strands
Superfamily: Immunoglobulin (IG)
Family: V set domains (antibody variable domain-like)
1GL4_B
Class: All beta proteins
Fold: Immunoglobulin-like beta-sandwich
sandwich; 7 strands in 2 sheets; greek-key some members of the fold have additional strands
Superfamily: Immunoglobulin (IG)
Family: I set domains
![Page 13: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/13.jpg)
Preliminary Results
Protein fold recognition Phyre
1nez_g
![Page 14: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/14.jpg)
Preliminary Results
Ⅰ Comparative Modeling
Swiss-Model
RAPTOR
![Page 15: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/15.jpg)
Preliminary Results
1MCP_H
(7~121)
Swiss-Model
![Page 16: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/16.jpg)
Preliminary Results
Swiss-Model
1a6w_L
![Page 17: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/17.jpg)
Discussion
Common
![Page 18: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/18.jpg)
Discussion
Differences
1MCP_H
1α-helix e f
![Page 19: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/19.jpg)
Discussion
Differences
1a6w_L
b c
2α-helices
e f
![Page 20: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/20.jpg)
Preliminary Results
RAPTOR
1a49_a
![Page 21: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/21.jpg)
Preliminary Results
1a49_a
1 α-helix: e f : Thr(83)~Ser(87)
![Page 22: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/22.jpg)
Preliminary Results
Ⅱ Secondary Structure and Tertiary Structure
Secondary Structure: PHD and Jnet
Tertiary Structure : HMMSTR
![Page 23: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/23.jpg)
Preliminary Results
PHD
![Page 24: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/24.jpg)
Preliminary Results
Jnet
![Page 25: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/25.jpg)
Discussion
Secondary Structure
PHD: 6 β-strands, no α-helix, not to be globular proteinV(8)~V(10), D(17)~C(20), V(32)~K(36), S(76)~N(81),
T(89)~L(94), V(107)~T(112)
Jnet: 8 β-strands, no α-helixV(8)~C(12), D(15)~T(21), T(31)~K(36), E(43)~T(47)
N(64)~D(68), Y(75)~N(81), T(89)~Q(95), G(104)~T(112)
![Page 26: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/26.jpg)
Preliminary Results
HMMSTR
![Page 27: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/27.jpg)
Discussion
HMMSTR
3 α- helices:
Asp(98)~Asn(102)
Pro(115)~Arg (118)
Lys(119)~Ile(130)
![Page 28: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/28.jpg)
Discussion
Comparison
A. Fold PatternComparative Modeling: distinguished hydrophobic core and hydrophilic side, regular, tight
HMMSTR: irregular, loose pattern, no related motif
![Page 29: Protein Folding of A Biopharmaceutical — hCD83](https://reader036.vdocuments.mx/reader036/viewer/2022070408/568143f1550346895db0796b/html5/thumbnails/29.jpg)
Discussion
Comparison
B. CompositionComparative Modeling: more beta-strands and loops
as well as hydrogen bonds
HMMSTR: less beta-strands, loops and hydrogen bonds